tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Advertisement

JW (Cayman) Therapeutics Co. Ltd. (2126) Revenue

Compare
0 Followers

JW (Cayman) Therapeutics Co. Ltd. Revenue

JW (Cayman) Therapeutics Co. Ltd. had a revenue of 106.35M in the quarter ending Jun 30, 2025, with 48.94%. This bring the company's revenue in the last twelve months to 177.75M, Decreased 12.34%. In the fiscal year ending Dec 31, 2024, JW (Cayman) Therapeutics Co. Ltd. had annual revenue of 158.22M with -8.99% growth.
Revenue (ttm)
177.75M
Revenue Growth
2.45%
P/S Ratio
11.32
Revenue/Employee
HK$563,053
Employees
281
Market Cap
HK$1.79B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
158.22M-15.64M+91.01%
Dec 31, 2023
173.86M28.15M+119.32%
Dec 31, 2022
145.70M114.91M+473.10%
Dec 31, 2021
30.80M-3,079,700,000.00%
Dec 31, 2020
-5.48M
Dec 31, 2019
5.48M5.27M+2,550.24%
Dec 31, 2018
215.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis